Serum amyloid-A levels in neonatal necrotizing enterocolitis

Journal of Clinical Laboratory Analysis

Volumn 25, Issue 4, 2011, Pages 233-237

  Eras, Zeynep ^a   Oǧuz, Suna ^a   Dizdar, Evrim Alyamac ^a   Sari, Fatma Nur ^a   Dilmen, Uǧur ^a  

^a Zekai Tahir Burak Maternity Teaching Hospital   (Turkey)

Author keywords

Necrotizing enterocolitis; Preterm; Serum amyloid A

Indexed keywords

SERUM AMYLOID A;

ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CONTROLLED STUDY; DIAGNOSTIC TEST; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE MARKER; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; INFANT; MALE; NECROTIZING ENTEROCOLITIS; NEWBORN; NEWBORN MONITORING; PATHOPHYSIOLOGY; PERINATAL PERIOD; PREMATURITY; PROTEIN BLOOD LEVEL; SEPSIS; TREATMENT RESPONSE;

BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; COHORT STUDIES; ENTEROCOLITIS, NECROTIZING; FEMALE; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; INFANT, PREMATURE, DISEASES; INTERLEUKIN-6; MALE; SEPSIS; SERUM AMYLOID A PROTEIN; STATISTICS, NONPARAMETRIC;

EID: 79960683231     PISSN: 08878013     EISSN: 10982825     Source Type: Journal    
DOI: 10.1002/jcla.20464     Document Type: Article

References (21)

1. Llanos AR, Moss ME, Pinzon MC, Dye T, Sinkin RA, Kendig JW. Epidemiology of neonatal necrotising enterocolitis: A population-based study. Paediatr Perinat Epidemiol 2002;16:342-349.
2. Kafetzis DA, Skevaki C, Costalos C. Neonatal necrotizing enterocolitis: an overview. Curr Opin Infect Dis 2003;16:349-355.
3. Kanto Jr WP, Hunter JE, Stoll BJ. Recognition and medical management of necrotizing enterocolitis. Clin Perinatol 1994;21:335-346.
4. Hallstrom M, Koivisto AM, Janas M, Tammela O. Laboratory parameters predictive of developing necrotizing enterocolitis in infants born before 33 weeks of gestation. J Pediatr Surg 2006;41:792-798.
5. O'Neill Jr JA, Holcomb Jr GW. Surgical experience with neonatal necrotizing enterocolitis (NNE). Ann Surg 1979;189:612-619.
6. Ververidis M, Kiely EM, Spitz L, Drake DP, Eaton S, Pierro A. The clinical significance of thrombocytopenia in neonates with necrotizing enterocolitis. J Pediatr Surg 2001;36:799-803.
7. Hutter Jr JJ, Hathaway WE, Wayne ER. Hematologic abnormalities in severe neonatal necrotizing enterocolitis. J Pediatr 1976;88:1026-1031.
8. Gabay C, Kushner I. Acute-phase proteins and other systemic responses to inflammation. N Engl J Med 1999;340:448-454.
9. Mayer JM, Raraty M, Slavin J, et al. Serum amyloid A is a better early predictor of severity than C-reactive protein in acute pancreatitis. Br J Surg 2002;89:163-171.
10. Bozinovski S, Hutchinson A, Thompson M, et al. Serum amyloid A is a biomarker of acute exacerbations of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2008;177:269-278.
11. Ng PC, Ang IL, Chiu RW, et al. Host-response biomarkers for diagnosis of late-onset septicemia and necrotizing enterocolitis in preterm infants. J Clin Invest 2010;120:2989-3000.
12. Grave GD, Nelson SA, Walker WA, et al. New therapies and preventive approaches for necrotizing enterocolitis: report of a research planning workshop. Pediatr Res 2007;62:510-514.
13. Lin PW, Nasr TR, Stoll BJ. Necrotizing enterocolitis: recent scientific advances in pathophysiology and prevention. Semin Perinatol 2008;32:70-82.
14. Upragarin N, Landman WJ, Gaastra W, Gruys E. Extrahepatic production of acute phase serum amyloid A. Histol Histopathol 2005;20:1295-1307.
15. Rosenthal CJ, Sullivan LM. Serum amyloid A to monitor cancer dissemination. Ann Intern Med 1979;91:383-390.
16. Niederau C, Backmerhoff F, Schumacher B, Niederau C. Inflammatory mediators and acute phase proteins in patients with Crohn's disease and ulcerative colitis. Hepatogastroenterology 1997;44:90-107.
17. Arnon S, Litmanovitz I, Regev RH, Bauer S, Shainkin-Kestenbaum R, Dolfin T. Serum amyloid A: an early and accurate marker of neonatal early-onset sepsis. J Perinatol 2007;27:297-302.
18. Jung SY, Park MC, Park YB, Lee SK. Serum amyloid A as a useful indicator of disease activity in patients with ankylosing spondylitis. Yonsei Med J 2007;48:218-224.
19. Kosuge M, Ebina T, Ishikawa T, et al. Serum amyloid A is a better predictor of clinical outcomes than C-reactive protein in non-ST-segment elevation acute coronary syndromes. Circ J 2007;71:186-190.
20. Lycopoulou L, Mamoulakis C, Hantzi E, et al. Serum amyloid A protein levels as a possible aid in the diagnosis of acute appendicitis in children. Clin Chem Lab Med 2005;43:49-53.
21. Arnon S, Litmanovitz I, Regev R, et al. Serum amyloid A protein is a useful inflammatory marker during late-onset sepsis in preterm infants. Biol Neonate 2005;87:105-110.